Product Name: Artesunate tablet
Nombre del Producto: Artesunato tableta
Package: 10tablets/blister/box, 1blister/box, 10blister/box
After parenteral administration, it is rapidly hydrolysed to the active metabolite dihydroartemisinin. The oral formulation is probably hydrolysed completely before entering the systemic circulation.
Artesunate has been reported to clear fever in patients with severe falciparum malaria 16-25 hours after parenteral administration.
Orally: treatment of uncomplicated falciparum malaria in areas where there is evidence of chloroquine, pyrimethamine/sulfadoxine, mefloquine and quinine resistance. It should always be administered together with mefloquine in full therapeutic dose.
Dosage and administration
Adults and children over 6 months: 5 mg/kg orally on the first day followed by 2.5 mg/kg on the second and third days in combination with mefloquine (15 mg/kg) in a single dose on the second day. In a few areas, a higher dose (25 mg/kg) of mefloquine may be required for a cure to be obtained.
Oral artesunate should not be used during the first trimester of pregnancy.
Use in pregnancy
Little experience has been gained with the use of this drug in pregnancy but the parenteral preparation should not be withheld if it is considered life-saving to the mother.
Drug-induced fever can occur.
Neurotoxicity has been observed in animal studies but not in humans. In view of the uncertainty about toxic effects, caution should be exercised when more than one 3-day treatment is given.
Cardiotoxicity has been observed following administration of high doses.
Tablets and powder for injection should be stored in tightly closed containers, protected from light.
Related Keywords: We are considered as one of the leading manufacturers and suppliers of artesunate tablets. With the aid of our technologically advanced manufacturing section, we are able to offer customers artesunate tablets products which are tested on various quality parameters in order to supply flawless range at the customers' end.